Literature DB >> 10197227

Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden.

P Montnémery1, E Adelroth, K Heuman, A Johannisson, S A Johansson, L H Lindholm, B Lundbäck, C G Löfdahl.   

Abstract

The prevalence of obstructive lung diseases is increasing in Scandinavia and worldwide. The reasons for this are not known. The prevalence varies between countries but also between different areas within the same country. In northern Europe a north-south gradient and also an east-west gradient have been proposed. To our knowledge this is the first comprehensive epidemiological study concerning obstructive lung diseases and respiratory symptoms in the southern part of Sweden. The prevalence of bronchial asthma, chronic bronchitis/emphysema, respiratory symptoms, smoking habits and medication in a random sample of 12,071 adults aged 20-59 years was assessed in a postal survey with a slightly modified questionnaire previously used in central and northern Sweden (the OLIN Studies). The questionnaire was based on the British Medical Research Council (BMRC) questionnaire. We also compared the prevalence figures of asthma found in the postal survey with those reported in the medical records in a part of the study area. After two reminders, the response rate was 70.1% (n = 8469); 33.8% of the responders were smokers. Among younger (20-39 year age group) individuals, smoking was most common in women, whereas in those aged 40-59 years, smoking was more common in men. In all, 469 subjects (5.5%) stated that they had asthma, 41.6% of whom reported a family history of asthma compared to 15.9% of the study sample not reporting asthma. Of all subjects reporting asthma, 60.1% (n = 282) answered that they used asthma drugs. Inhaled steroids were used by 20.7%. Chronic bronchitis and/or emphysema was reported by 4.6% (n = 392), 28.6% of whom reported a family history of chronic bronchitis or emphysema compared to 6.8% of the study sample not reporting chronic bronchitis. The most common respiratory symptom in the study population was 'phlegm when coughing' reported by 15.1% (n = 1279). Our data show a prevalence of self-reported asthma of 5.5% compared with 7% reported by Lunbäck et al. in northern Sweden, which indicates a north-south gradient.

Entities:  

Mesh:

Year:  1998        PMID: 10197227     DOI: 10.1016/s0954-6111(98)90139-1

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  18 in total

Review 1.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

2.  The impact of chronic cough: a cross-sectional European survey.

Authors:  Sarah A F Chamberlain; Rachel Garrod; Abdel Douiri; Sarah Masefield; Pippa Powell; Catherine Bücher; Anand Pandyan; Alyn H Morice; Surinder S Birring
Journal:  Lung       Date:  2015-03-19       Impact factor: 2.584

3.  Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.

Authors:  Martin Söderholm; Malin Inghammar; Bo Hedblad; Arne Egesten; Gunnar Engström
Journal:  Eur J Epidemiol       Date:  2015-12-28       Impact factor: 8.082

4.  Risk of chronic bronchitis in twin pairs discordant for smoking.

Authors:  Howraman Meteran; Simon Francis Thomsen; Lotte Harmsen; Kirsten Ohm Kyvik; Axel Skytthe; Vibeke Backer
Journal:  Lung       Date:  2012-06-19       Impact factor: 2.584

5.  Familial related risk-factors in the development of chronic bronchitis/emphysema as compared to asthma assessed in a postal survey.

Authors:  P Montnémery; J Lanke; L H Lindholm; B Lundbäck; P Nyberg; E Adelroth; C G Löfdahl
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

6.  Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trondelag Health Study (HUNT).

Authors:  A Langhammer; R Johnsen; J Holmen; A Gulsvik; L Bjermer
Journal:  J Epidemiol Community Health       Date:  2000-12       Impact factor: 3.710

7.  COPD and the risk of tuberculosis--a population-based cohort study.

Authors:  Malin Inghammar; Anders Ekbom; Gunnar Engström; Bengt Ljungberg; Victoria Romanus; Claes-Göran Löfdahl; Arne Egesten
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ).

Authors:  E Piitulainen; T Sveger
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

9.  Interaction between smoking and genetic factors in the development of chronic bronchitis.

Authors:  Jenny Hallberg; Annica Dominicus; Ulrika K Eriksson; Maria Gerhardsson de Verdier; Nancy L Pedersen; Magnus Dahlbäck; Ulf Nihlén; Tim Higenbottam; Magnus Svartengren
Journal:  Am J Respir Crit Care Med       Date:  2007-11-29       Impact factor: 21.405

10.  Environmental exposure as an independent risk factor of chronic bronchitis in northwest Russia.

Authors:  Pentti Nieminen; Dmitry Panychev; Sergei Lyalyushkin; German Komarov; Alexander Nikanov; Mark Borisenko; Vuokko L Kinnula; Tuula Toljamo
Journal:  Int J Circumpolar Health       Date:  2013-02-22       Impact factor: 1.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.